FL118, acting as a ‘molecular glue degrader’, binds to, dephosphorylates and degrades the oncoprotein DDX5 (p68) to control c‐Myc, survivin and mutant Kras against colorectal and pancreatic cancer with high efficacy is a research paper published in Clinical and Translational Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 40 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Pancreatic Cancer Action Network
Grant: 20‐65‐FENG
National Cancer Institute
Grant: R21CA180764
National Cancer Institute
Grant: R03CA182552
National Cancer Institute
Grant: R44CA176937
National Cancer Institute
Grant: P30CA016056
U.S. Department of Defense
Grant: W81XWH‐12‐1‐0305/PC110408
National Institutes of Health
Grant: 1R21CA180764-01A1
An inhibitor of multiple anti-apoptotic gene products for pancreatic cancer
National Institutes of Health
Grant: 1R03CA182552-01
A novel regimen to target both pancreatic cancer K-ras and antiapoptotic proteins
National Institutes of Health
Grant: 5R44CA176937-03
A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer
National Institutes of Health
Grant: 5P30CA016056-40
Roswell Park Cancer Institute Cancer Center Support Grant
National Institutes of Health
FWCI
2.59
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals